On #WorldTBDay, MSF urges governments and donors to put children at the heart of the global TB response. Sustained funding is needed to diagnose, treat, and prevent TB in children, who remain one of the most vulnerable groups.    msfaccess.org/msf-demands-...

Why half of the 1.2 million children with TB cannot access diagnosis and lifesaving treatment? Watch this video to learn more. #WorldTBDay     www.youtube.com/watch?v=6k6Y...

Drawing on MSF’s frontline experience across emergencies, we’re calling on EU to progress towards a system that ensures fair and equitable benefit‑sharing in exchange for access to pathogens and genetic resources used in R&D, including clinical trials. msfaccess.org/msf-calls-eu...

In 2011, more than 3,000 people marched in India to oppose harmful provisions that could have been included in EU–India free trade agreement and threatened access to affordable medicines. Fifteen years later, after two decades of sustained advocacy, those were excluded from the final deal.

India-EU free trade agreement full text has been released and the intellectual property chapter: 👍Largely preserves India’s public health safeguards and doesn't go beyond @wto.org TRIPS agreement 🛑 BUT 🛑

In 2014, I visited eastern DRC, where @msf.org teams were treating sleeping sickness - the only available treatment was a drug so toxic it killed 1 in 20 patients. In 2026 I'm so proud that, thanks to @dndi.org, patients can be cured with a single dose of a groundbreaking new oral drug, acoziborole.

🚀 Huge news for people living with #sleepingsickness! Acoziborole, a one-day, single-dose oral treatment developed with Sanofi, has received a positive opinion from @ema.europa.eu for the treatment of the most common form of sleeping sickness. 👉 bit.ly/46ZFpEi

Thanks @madhupai.bsky.social for the spotlight on TB in Europe. Additionally, lack of access to treatment due to unavailability, high prices, and fragmented supply of TB medicines remains a major challenge. Critical DR-TB meds are exorbitantly priced in the region: some over 100x than in LMICs!

Read MSF’s recommendations for a strong WHO Pathogen Access and Benefit-Sharing (PABS) system calling for reliable, equitable and accountable access to vaccines, diagnostics and treatments developed from shared samples and data. msfaccess.org/ensuring-col...

👉 @msfbrasil.bsky.social is seeking to intervene in a Supreme Court case challenging Brazil’s new law on research, which limits the right of clinical trial participants to receive free access to medicines developed from the studies they joined.

MSF representatives addressed critical issues in fragile settings at the @who.int Executive Board #EB158 this week, calling for urgent action on: 🔹Antimicrobial resistance (AMR) 🔹Mental health 🔹Noncommunicable diseases (NCDs) 🔹Vaccines Read the statements: msfaccess.org/msf-statemen...

...and the harmful consequences of the Trump administration’s drive to reshape US foreign assistance have only just started to unfold.

Great read: an MSF reflection on antimicrobial evidence gaps and implementation needs in humanitarian settings, grounded in MSF's work in fragile contexts.

Why is #insulin, an essential and lifesaving medication that’s existed for over 100 years, still priced, patented, and distributed like a 💎luxury good💎? Listen as our advocacy advisor, Candice Sehoma, unpacks it on this #podcast episode: open.spotify.com/episode/6p39...

From Forest to Factory analyzes global supply chains for 2 critical vaccine adjuvants, QS-21 and MPL — used in vaccines for malaria, shingles, RSV, & a leading tuberculosis vaccine candidate. Read the full report here: www.treatmentactiongroup.org/publication/...

Yesterday, 175 governments pledged to accelerate responses to NCDs & mental health. Now they must take concrete actions to ensure everyone has affordable access to the medical tools they need. msfaccess.org/governments-...

Do you know how #algorithms can help diagnose the world's deadliest infectious disease? Find out in our latest newsletter 👇 msfaccess.org/newsletter/a...

Along with 10 other civil society organisations, we sent an open letter to the European Parliament’s Committee on Public Health, sharing recommendations to ensure that the Critical Medicines Act advances equitable access for all. msfaccess.org/cso-open-let...

Yesterday, at Abrascão, Brazil's largest public health congress, MSF Access' Marcela Vieira explored how patent monopolies raise prices, limit access to health products, and deepen health inequities... and she shared a way to challenge them: www.patentoppositions.org

Novo Nordisk discontinues key insulin products in EU/EEA for commercial reasons: “Yet another unacceptable example of pharmaceutical corporations putting profits before people’s health.” msfaccess.org/msf-responds...

Negotiations on the Pathogen Access and Benefit Sharing (PABS) system, a key aspect of the WHO Pandemic Agreement adopted in May this year, began today. Read our statement and asks: msfaccess.org/msf-welcomes...

Happening tomorrow!

On World Children’s Day (20 Nov 2025), TB activists and MSF marched in solidarity with children affected by tuberculosis at the Union World Conference on Lung Health in Copenhagen. To learn more about MSF’s work and engagement on TB in children, visit: www.msf.org/tactic-tuber...

On #WorldAMRAwarenessWeek, we’re calling for concrete action to ensure access to existing diagnostic tools, microbiology capacities, legacy & new lifesaving antibiotics, and care for all... + an increase in R&D for low-resource & humanitarian settings, where it's most needed.

🦠 By 2050, AMR is estimated to contribute to 8.2 million deaths worldwide. For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe. #WorldAMRAwarenessWeek

AMR, FTAs, TB, do you know what these acronyms mean, and what they have to do with access to health products? If you're curious, read our latest newsletter, and sign up for more access content! msfaccess.org/newsletter/a...

This World AMR Awareness Week, join a discussion on antimicrobial resistance in conflict-affected settings, where AMR's impact is severe due to limited access to infection prevention, diagnostics, and antimicrobials. 📅 Thur 20 Nov 🕐 13:30 – 15:00 CET fao.zoom.us/webinar/regi...

Today at @theunion.org we unveiled data from our operational research: ⚙️ @who.int recommended algorithms, for diagnosing tuberculosis in children can nearly double the number of children who can be initiated on lifesaving treatment. 🎉 msfaccess.org/msf-findings...

Today is World Diabetes Day. More than 800 million people have diabetes, most of whom live in low- and middle-income countries. For people w/ type 1 diabetes, insulin is lifesaving, but it's often unavailable in low-resource and emergency settings and unaffordable elsewhere.

Scientists discovered insulin over 100 years ago, envisioning a world where everyone could access #diabetes treatment. But it is often unavailable or unaffordable. Ahead of World Diabetes Day tomorrow, we’re calling for affordable & available insulin pens for all.

It's starting soon! www.youtube.com/watch?v=XBqQ...

Today @who.int released their 2025 #tuberculosis report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap! msfaccess.org/msf-responds...

Half of children and young adolescents with tuberculosis are not diagnosed and therefore do not receive lifesaving treatment… but why? Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion. youtu.be/6k6YCqPUi_Y

Every child withTB deserves a healthy childhood. Yet in 2023, 1.25M fell ill with TB and nearly half were never diagnosed, thus never treated. Join our webinar moderated by @johngreensbluesky.bsky.social where survivors and treatment providers will discuss how to close these deadly gaps.

🦠 It's estimated that by 2050, antibiotic resistance will cause 8.22 million deaths per year. To try and combat this, MSF launched Antibiogo, a free diagnostic aid app to combat antibiotic resistance by improving access to patient diagnoses. Learn more:

➡️ @saludporderecho.bsky.social reports that in Spain the public price of WHO recommended six-month treatment BPaLM regimen is priced at €58,000. In contrast, LMICs can access the same regimen for less than €250. saludporderecho.org/en/monopolie...

💊Patents, trade policy, and why people's access to the medicines they need is at stake.   MSF's Roshan John Joseph on India’s Free Trade Agreements with high-income countries, how they could mean higher medicine prices around the world, and why transparency in their negotiation matters.

MSF first witnessed the systemic gaps in access to WHO-recommended #tuberculosis treatments in 2022 when we launched a response in Poland to assist Ukrainian refugees and other migrants in accessing tuberculosis treatment. A TB survivor shared her experience 🧵

At a panel discussion yesterday in Brussels, we urged policymakers, parliamentarians, regulatory agencies, and procurement bodies in the EU and the EEA to take urgent steps to bridge the gap in accessing tuberculosis treatment in the region. msfaccess.org/msf-urges-eu...

⏰ Tomorrow! Don’t miss our panel on improving access to TB medicines in EU/EEA. People with TB still face barriers to effective treatment & prevention, let's discuss solutions. Register Now👉 us06web.zoom.us/webinar/regi...

People with TB in EU and EEA still face limited access to effective treatment and prevention medicines. How can we fix that? On 14 Oct, join our panel discussion on how to improve the availability and affordability of TB medicines in the region. Register us06web.zoom.us/webinar/regi...

Ahead of the WHO Eastern Mediterranean Regional Committee, MSF shared challenges in addressing antimicrobial resistance in fragile & conflict settings, where it's critical to measure access gaps & improve availability of diagnostics & antibiotics. www.emro.who.int/media/news/i...

While most countries agreed to the UN HLM Declaration on prevention & control of NCDs & mental health, it was not adopted. We urge countries to adopt the Declaration as it stands at the earliest opportunity & act to ensure equitable & affordable access to medical tools for all.

We welcome the agreement to provide ground-breaking HIV prevention drug at $40 in 2027, but global plans need to prioritise key populations and include the low- and middle-income countries to ensure sustainable access for all who need it. msfaccess.org/msf-supports...

⏰ Tomorrow, governments will gather at the United Nations High Level Meeting (UN HLM) in New York to agree to a political declaration that will guide them on how to prevent and control noncommunicable diseases (NCDs) – including diabetes – and mental health until 2030. 🧵

What happens when people face challenges accessing the diabetes care they need? Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred. msfaccess.org/what-it-mean...

Scientists who discovered #insulin over 100 years ago envisioned a world where everyone could access diabetes treatment. And yet, diabetes treatment is too often unavailable or unaffordable. Learn more ⬇️ youtube.com/watch?v=v6R17w1pD0A&feature=youtu.be

Fleeing home while managing #diabetes can mean losing reliable access to insulin which, in turn, risks severe health consequences, even death. Ghassan undertook a long, difficult journey with a limited supply of insulin. How did he manage his treatment? 🧵

Managing #diabetes while living through a conflict can be challenging, especially when access to medical tools is disrupted. After the war broke out in Lebanon in 2024, Sana (14) had to change the way she monitored her blood glucose levels. 🧵 youtu.be/eg0BAJKtTXI

Even with access to the best tools, technology, and treatment, managing diabetes is complicated. What happens when people face challenges accessing the diabetes care they need due to corporate decisions, displacement, or conflict? 🧵